NCT01916187View on ClinicalTrials.gov

Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 30, 2013

Primary Completion Date

November 22, 2013

Study Completion Date

January 16, 2014

Conditions
Neuroblastoma
Interventions
DRUG

Imetelstat

Trial Locations (1)

H3T 1C5

CHU Sainte-Justine, Montreal

Sponsors

Collaborators (1)

Geron Corporation
All Listed Sponsors
collaborator

Geron Corporation

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK

NCT01916187 - Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma | Biotech Hunter | Biotech Hunter